Ambra Health, iSchemaView partner on stroke imaging

Cloud-based software company Ambra Health has installed a dedicated server...Read more on AuntMinnie.comRelated Reading: iSchemaView adds to AI software offerings iSchemaView scores Japanese approval for Rapid software iSchemaView brings Rapid software to Mexico Ambra expands customer list Ambra Health receives 2 contracts Ambra Health teams with Google on research
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news

Related Links:

Publication date: Available online 28 March 2020Source: Materials Today: ProceedingsAuthor(s): S. Godwin Barnabas, S. Valai Ganesh, V. Sivakumar, P. Muthukumar, A. Dhinesh Raja, K. Hariharan
Source: Materials Today: Proceedings - Category: Materials Science Source Type: research
Publication date: Available online 28 March 2020Source: Journal of Clinical NeuroscienceAuthor(s): Akemi Hioka, Yoshiteru Tada, Keiko Kitazato, Naoki Akazawa, Yasushi Takagi, Shinji Nagahiro
Source: Journal of Clinical Neuroscience - Category: Neuroscience Source Type: research
In this study, we review various types of AF, proposed mechanisms, and treatment strategies for athletes with AF.
Source: Strength and Conditioning Journal - Category: Sports Medicine Tags: Article Source Type: research
Source: BMJ Comments - Category: General Medicine Source Type: forums
We report a 42-year old men who presented to our observation with acute tongue swelling and atrophy of left side of tongue from a hypoglossal nerve injury. A magnetic resonance imaging revealed a denervation of the left half of the tongue from a hypoglossal nerve injury due to left extracranial internal carotid artery (ICA) dissection, without evidence of ischemic stroke. The urine toxicology screen test revealed a positivity for cocaine. This case report suggest to perform in young patient a toxicological drug screening test in presence of ICA dissection with hypoglossal nerve injury and an acute tongue swelling. However ...
Source: Psychopharmacology Bulletin - Category: Psychiatry & Psychology Tags: Psychopharmacol Bull Source Type: research
In the face of COVID-19, neurologists working in stroke, epilepsy, dementia, and other subspecialties are tasked with a quick pivot from in-office patient visits to a new era of online consultations.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news
This study aimed to define the effects of LSZ on proinflammatory mediators and neuroprotective effects on middle cerebral artery occlusion and refusion (MCAO/R) rats. Rats were treated with different doses of LSZ (0.54, 1.62, and 4.32 g/(kg·d)) in a week after model building. LSZ could improve the survival rate, ischemic stroke outcome, and infarct volume. In addition, significant decrease was observed in reactive oxygen species (ROS) levels and inflammatory factor levels in LSZ-treated groups, concomitant with increase in activities of superoxide dismutase (SOD), neurosynaptic remodeling, and decrease in bra...
Source: Evidence-based Complementary and Alternative Medicine - Category: Complementary Medicine Tags: Evid Based Complement Alternat Med Source Type: research
Publication date: Available online 5 March 2020Source: World Journal of Acupuncture - MoxibustionAuthor(s): Ling-shu WANG, Guan-nan LI, Xue-tong GU, Yuan-yuan BI, Chun-yu ZHANG
Source: World Journal of Acupuncture Moxibustion - Category: Complementary Medicine Source Type: research
RARITAN, NJ, March 28, 2020 – The Janssen Pharmaceutical Companies of Johnson &Johnson today announced the VOYAGER PAD study met its primary efficacy and principal safety endpoints, demonstrating the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily) plus aspirin (100 mg once daily) was superior to aspirin alone in reducing the risk of major adverse limb and cardiovascular (CV) events by 15 percent in patients with symptomatic peripheral artery disease (PAD) after lower-extremity revascularization, with similar rates of TIMI[1] major bleeding. VOYAGER PAD is the only study to show a significant benefit...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
Authors: Viswanathan V, Jamthikar AD, Gupta D, Puvvula A, Khanna NN, Saba L, Viskovic K, Mavrogeni S, Turk M, Laird JR, Pareek G, Miner M, Ajuluchukwu JNA, Sfikakis PP, Protogerou A, Kitas GD, Nicolaides A, Sharma A, Suri JS Abstract BACKGROUND: Recently, a 10-year image-based integrated calculator (called AtheroEdge Composite Risk Score-AECRS1.0) was developed which combines conventional cardiovascular risk factors (CCVRF) with image phenotypes derived from carotid ultrasound (CUS). Such calculators did not include Chronic Kidney Disease (CKD)-based biomarker called estimated glomerular filtration rate (eGFR). The...
Source: International Angiology - Category: Cardiology Tags: Int Angiol Source Type: research
More News: Contracts | Japan Health | Mexico Health | Radiology | Stroke